CD274 and non-small cell lung carcinoma: Although immune checkpoint inhibitors alone have not shown improved overall survival compared to chemotherapy in patients with EGFR-mutated advanced NSCLC [8], the significance of high PD-L1 expression levels has been increasingly recognized.